BIOATLA INC's ticker is BCAB and the CUSIP is 09077B104. A total of 80 filers reported holding BIOATLA INC in Q2 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,405,535 | -42.9% | 4,356,197 | +0.8% | 0.68% | -52.6% |
| Q2 2023 | $12,963,591 | +11.9% | 4,321,197 | 0.0% | 1.44% | +20.2% |
| Q1 2023 | $11,580,808 | -66.7% | 4,321,197 | +2.4% | 1.20% | -76.0% |
| Q4 2022 | $34,818,275 | +33.0% | 4,220,397 | +24.1% | 5.00% | +40.4% |
| Q3 2022 | $26,184,000 | +181.6% | 3,400,503 | +4.2% | 3.56% | +145.2% |
| Q2 2022 | $9,299,000 | -26.1% | 3,262,703 | +29.7% | 1.45% | -10.6% |
| Q1 2022 | $12,577,000 | -74.5% | 2,515,424 | 0.0% | 1.62% | -67.2% |
| Q4 2021 | $49,378,000 | -33.3% | 2,515,424 | 0.0% | 4.94% | -57.2% |
| Q3 2021 | $74,054,000 | -37.5% | 2,515,424 | -10.0% | 11.54% | -36.6% |
| Q2 2021 | $118,420,000 | -26.7% | 2,794,233 | -12.1% | 18.21% | -37.5% |
| Q1 2021 | $161,639,000 | +49.5% | 3,179,362 | 0.0% | 29.12% | +104.1% |
| Q4 2020 | $108,130,000 | – | 3,179,362 | – | 14.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 3,624,076 | $9,712,524 | 1.45% |
| Soleus Capital Management, L.P. | 4,321,197 | $11,580,808 | 1.20% |
| Affinity Asset Advisors, LLC | 325,000 | $871,000 | 0.29% |
| SECTORAL ASSET MANAGEMENT INC | 543,009 | $1,455,264 | 0.28% |
| Cormorant Asset Management, LP | 1,181,115 | $3,165 | 0.21% |
| Orbimed Advisors | 3,861,000 | $10,347,480 | 0.20% |
| Vivo Capital, LLC | 637,181 | $1,707,645 | 0.12% |
| Boxer Capital, LLC | 686,347 | $1,839 | 0.09% |
| Atom Investors LP | 55,476 | $148,676 | 0.08% |
| MYDA Advisors LLC | 55,000 | $147,400 | 0.06% |